NovaMed Adds Seven New Partners to Its Orlando Surgery Center
September 29 2010 - 9:35AM
Business Wire
NovaMed, Inc. (Nasdaq: NOVA), a leading operator of ambulatory
surgery centers (ASCs) in partnership with physicians, today
announced that its majority-owned ASC located in Orlando, Florida
(d/b/a Downtown Surgery Center) acquired certain assets of a
multi-specialty ASC in the market. As a result of the transaction,
the operations of the acquired ASC have been merged into Downtown
Surgery Center and three physician-partners and a hospital-partner
of the acquired ASC have become partners in Downtown Surgery
Center. The three new physician-partners perform orthopedic,
ophthalmology and general surgery procedures.
Separately, NovaMed is also pleased to announce that three other
local physicians have become partners in Downtown Surgery Center.
One of these physicians is an orthopedic surgeon and the other two
are general surgeons. NovaMed now owns 62% of Downtown Surgery
Center with the remaining 38% owned by seven physician-partners and
a hospital-partner.
“We are excited to welcome our new partners and look forward to
working with each of them at our state-of-the-art surgery center,”
commented Thomas S. Hall, Chairman, President and Chief Executive
Officer of NovaMed, Inc. “We opened Downtown Surgery Center in
January 2009 with our partner, Dr. George White, a highly respected
orthopedic surgeon. Downtown Surgery Center has four operating
rooms and one procedure room and is managed by our experienced and
capable staff. We have plenty of capacity to accommodate our new
partners as well as other local surgeons that we hope will choose
to use our surgery center.”
Mr. Hall concluded, “This acquisition represents the execution
of the strategy we have articulated of identifying underperforming
ASCs in our existing markets with the plan of folding the
operations into our own surgery center. We believe this is a great
opportunity to achieve growth and add value to our existing
portfolio with a relatively low capital commitment and we plan to
pursue more of these types of acquisitions. In addition, this
transaction brings our second hospital partner to our portfolio
which we continue to believe helps to strengthen our position in
certain markets.”
About NovaMed
NovaMed operates, develops and acquires ambulatory surgery
centers in partnership with physicians and holds majority ownership
interests in 37 surgery centers located in 19 states. Learn more at
www.novamed.com.
This press release contains forward-looking statements that
relate to possible future events. These statements are based on
management’s current expectations and are subject to risks and
uncertainties, which could cause our actual results to differ
materially from those expressed or implied in this press release.
These risks and uncertainties include: the current difficult
economy and tightened credit markets; our current and future debt
levels; our ability to access capital on a cost-effective basis to
continue to successfully implement our growth strategy; reduced
prices and reimbursement rates for surgical procedures; our ability
to acquire, develop or manage a sufficient number of profitable
surgical facilities; our ability to maintain successful
relationships with the physicians who use our surgical facilities;
our ability to grow and manage effectively our increasing number of
surgical facilities; competition from other companies in the
acquisition, development and operation of surgical facilities; and
uncertainty around national healthcare reform and the application
of existing or proposed government regulations, or the adoption of
new laws and regulations, that could limit our business operations,
require us to incur significant expenditures or limit our ability
to relocate our facilities if necessary. Readers are encouraged to
review a more complete discussion of the factors affecting
NovaMed’s business and prospects in its filings with the Securities
and Exchange Commission, including the company’s 2009 Form 10-K
filed on March 16, 2010. Readers should not place undue reliance on
any forward-looking statements. Except as required by the federal
securities laws, NovaMed undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events, changing circumstances or
any other reason after the date of this press release.
Novamed (NASDAQ:NOVA)
Historical Stock Chart
From Dec 2024 to Jan 2025
Novamed (NASDAQ:NOVA)
Historical Stock Chart
From Jan 2024 to Jan 2025